Health Care: Drugs

Celgene Corp (CELG: NASDAQ)

$124.04 n/a | n/a%
08/28/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 124.04
52 Week High 140.72
52 Week Low 83.16
Avg. Daily Vol. (Mil) 4.80
Beta (3 year) 2.07
Share Related Items
Mkt Cap (Mil) 98,058.60
Shares Out (Mil) 790.54
Float (Mil) 791.04
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.00
Current Ratio 3.30
LT Debt/ Equity 0.99
Total Debt / Equity 1.21
Valuation Ratios
Price Earnings 47.00
Price/Sales 11.64
Price/Book 15.51
Price/Cash Flow 38.10
Per Share Data
Earnings 2.64
Sales 10.66
Book Value 8.00
Cash Flow 3.25
Business Summary
Celgene Corp is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
General Information
86 Morris Avenue
Summit, NJ 07901
www.celgene.com
Industry : Drugs
Sector: Health Care
Employees: 6012
CEO: Robert J. Hugin
Short Interest
Current Month (Mil) 10.64
Previous Month (Mil) 11.21
Short Interest Ratio (Days) 2.00
Management Effectiveness
Return on Equity 34.80
Return on Assets 12.40
Return on Investments 17.50
Profitability
Gross Margin 96.60
EBIT Margin 33.10
Profit Margin 26.10

Portfolios with CELG

Latest CELG Headlines from TheStreet

More Financial News for CELG

Press Releases for CELG

See All Press Releases

Partner Headlines for CELG

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter